Novo Nordisk steps up interest in diabetes, Parkinson’s stem cell therapies – FierceBiotech
FierceBiotech |
Novo Nordisk steps up interest in diabetes, Parkinson's stem cell therapies
FierceBiotech Novo Nordisk has talked up the progress of its Type 1 diabetes stem cell therapy program. With the diabetes project clearing milestones and moving to within a few years of the clinic, Novo is stepping up its interest in stem cell therapies more broadly. Citing significant progress on a cure for diabetes, Novo Nordisk beefs up its stem cell pipeline with new collaborations Novo expands type 1 diabetes R&D |
